Literature DB >> 27385238

Medical Marijuana Laws Reduce Prescription Medication Use In Medicare Part D.

Ashley C Bradford1, W David Bradford2.   

Abstract

Legalization of medical marijuana has been one of the most controversial areas of state policy change over the past twenty years. However, little is known about whether medical marijuana is being used clinically to any significant degree. Using data on all prescriptions filled by Medicare Part D enrollees from 2010 to 2013, we found that the use of prescription drugs for which marijuana could serve as a clinical alternative fell significantly, once a medical marijuana law was implemented. National overall reductions in Medicare program and enrollee spending when states implemented medical marijuana laws were estimated to be $165.2 million per year in 2013. The availability of medical marijuana has a significant effect on prescribing patterns and spending in Medicare Part D. Project HOPE—The People-to-People Health Foundation, Inc.

Entities:  

Keywords:  Medicare Part D; medical marijuana; state policy

Mesh:

Substances:

Year:  2016        PMID: 27385238     DOI: 10.1377/hlthaff.2015.1661

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  92 in total

1.  Is There Less Opioid Abuse in States Where Marijuana Has Been Decriminalized, Either for Medicinal or Recreational Use? A Clin-IQ.

Authors:  Aaron M Wendelboe; Richard Mathew; Tana Chongsuwat; Elizabeth Rainwater; Mark A Wendelboe; Elizabeth Wickersham; Ann F Chou
Journal:  J Patient Cent Res Rev       Date:  2019-10-28

2.  Recreational marijuana legalization and prescription opioids received by Medicaid enrollees.

Authors:  Yuyan Shi; Di Liang; Yuhua Bao; Ruopeng An; Mark S Wallace; Igor Grant
Journal:  Drug Alcohol Depend       Date:  2018-10-25       Impact factor: 4.492

3.  Do medical marijuana laws reduce addictions and deaths related to pain killers?

Authors:  David Powell; Rosalie Liccardo Pacula; Mireille Jacobson
Journal:  J Health Econ       Date:  2018-02-03       Impact factor: 3.883

4.  Good Samaritan harm reduction policy and drug overdose deaths.

Authors:  Danielle N Atkins; Christine Piette Durrance; Yuna Kim
Journal:  Health Serv Res       Date:  2019-02-11       Impact factor: 3.402

5.  Should Medical Cannabis Administered by Inhalation Be Allowed for Hospitalized Patients?

Authors: 
Journal:  Can J Hosp Pharm       Date:  2018-06-28

6.  Why Marijuana Will Not Fix the Opioid Epidemic.

Authors:  Kenneth Finn
Journal:  Mo Med       Date:  2018 May-Jun

Review 7.  Cannabis regulatory science: risk-benefit considerations for mental disorders.

Authors:  Jacob T Borodovsky; Alan J Budney
Journal:  Int Rev Psychiatry       Date:  2018-05-29

8.  Qualifying Conditions Of Medical Cannabis License Holders In The United States.

Authors:  Kevin F Boehnke; Saurav Gangopadhyay; Daniel J Clauw; Rebecca L Haffajee
Journal:  Health Aff (Millwood)       Date:  2019-02       Impact factor: 6.301

9.  State medical marijuana laws, cannabis use and cannabis use disorder among adults with elevated psychological distress.

Authors:  Ryan K McBain; Eunice C Wong; Joshua Breslau; Amy L Shearer; Matthew S Cefalu; Elizabeth Roth; M Audrey Burnam; Rebecca L Collins
Journal:  Drug Alcohol Depend       Date:  2020-07-24       Impact factor: 4.492

10.  How Medical Marijuana Smoothed the Transition to Marijuana Legalization in the United States.

Authors:  Beau Kilmer; Robert J MacCoun
Journal:  Annu Rev Law Soc Sci       Date:  2017-07-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.